Kyle Pepi is a Scientist II at Seres Therapeutics, with previous experience as a Scientist I at the same company, as well as Senior Analyst and Analyst II at ZeptoMetrix Corporation. Their background includes roles as a QC Testing Laboratory Associate at ZeptoMetrix Corporation, a Merchandiser at Burke Distributing Corporation, and a Maintenance Associate at Horizon Beverage. Kyle holds a Bachelor's Degree in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.
January 1, 2024 - present
January, 2022
January, 2020
July, 2017